NCT04416243

Brief Summary

There is considerable evidence to support the efficacy of moderate intensity continuous (MIC) exercise benefitting clinically-relevant outcomes in persons with multiple sclerosis (MS). However, persons with MS who have walking impairments (pwMS-wd) are severely deconditioned and may achieve superior benefits by engaging in high-intensity interval training (HIIT), especially while utilizing adaptive equipment, such as with recumbent arm/leg stepping (RSTEP). Of the published studies on HIIT in MS, HIIT yielded significant improvements in cardiorespiratory fitness in all but one study. In those studies that directly compared HIIT to MIC exercise, the data indicated a potential superiority of HIIT as compared to MIC in improving physiological conditioning in a time efficient manner. However, this evidence is specific to those with MS with mild to moderate disability engaging in cycle/arm ergometry and an investigation of HIIT in pwMS-wd is needed as the feasibility and potential benefits of engaging in HIIT in pwMS-wd is relatively unknown. The primary aim of the proposed study is to assess the feasibility of a 12-week, RSTEP HIIT program in pwMS-wd. The secondary aim is to examine changes in aerobic fitness, physical activity, ambulation, upper arm function, cognition, fatigue, and depressive symptoms as clinically-relevant efficacy outcomes following the 12-week, RSTEP HIIT intervention. It is hypothesized that the intervention will be feasible and lead to positive changes in aerobic fitness, physical activity, ambulation, upper arm function, cognition, fatigue, and depressive symptoms. This work is informed by recently published data, which indicate that a single bout of RSTEP HIIT taxes the cardiorespiratory system significantly more than MIC exercise, yet without untoward effects on walking, gait, cognition, mood, or enjoyment. These data suggest that RSTEP HIIT may be an acceptable, safe, and tolerable stimulus for chronic exercise training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 19, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2022

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

3 years

First QC Date

May 28, 2020

Last Update Submit

April 14, 2023

Conditions

Keywords

multiple sclerosisadaptive equipmentrehabilitationrecumbent steppinghigh-intensity interval training

Outcome Measures

Primary Outcomes (6)

  • Recruitment, Retention, and Adherence Rates

    Participant recruitment, retention, and adherence rates will be recorded.

    From recruitment to end of treatment at 12 weeks.

  • Time Needs

    Staff training, communication, recruitment, and intervention time will be recorded.

    From recruitment to end of treatment at 12 weeks.

  • Monetary Needs

    Monetary research costs will be recorded.

    From recruitment to end of treatment at 12 weeks.

  • Data Management and Safety Reporting

    Time from submission of Institutional Review Board application to approval will be recorded. All time spent collecting, entering, and checking data will be recorded.

    From recruitment to end of treatment at 12 weeks.

  • Participant Burden Reporting

    Participants' experience, burden, and perceptions will be assessed via a short survey at the end of the 12 weeks.

    From recruitment to end of treatment at 12 weeks.

  • Safety Reporting

    Adverse events, serious adverse events, and clinical emergencies will be recorded.

    From recruitment to end of treatment at 12 weeks.

Secondary Outcomes (8)

  • Change in Aerobic Capacity

    Week 0, Following Week 6, Following Week 12

  • Change in 6-Minute Walk Distance

    Week 0, Following Week 6, Following Week 12

  • Change in 25-Foot Walk Speed

    Week 0, Following Week 6, Following Week 12

  • Change in Sedentary, Light, and Moderate-to-Vigorous Counts of Physical Activity

    Week 0, Following Week 6, Following Week 12

  • Change in the Brief International Cognitive Assessment in MS Scores

    Week 0, Following Week 6, Following Week 12

  • +3 more secondary outcomes

Study Arms (1)

Recumbent Stepping, High-Intensity Interval Training

EXPERIMENTAL
Behavioral: Recumbent Stepping, High-Intensity Interval Training

Interventions

The intervention will involve 12 weeks of supervised, progressive (i.e., intensity increases after midpoint testing based on reassessment of aerobic fitness) HIIT sessions two to three times per week. HIIT exercise sessions will be manualized and led by exercise leaders. Secondary outcomes testing will occur at baseline (week 0), midpoint (following week 6 of training), and post-intervention (following week 12 of training). The individual HIIT sessions will involve 10 cycles of 60s intervals at the wattage associated with 90% VO2peak followed by 60s of active recovery intervals at 15 watts, totaling 20 min in length. All exercise sessions will begin and end with a 5-minute warm-up and cool-down, respectively. Required power output for each interval of the exercise session will be individualized and completely automated. VO2peak from baseline and midpoint testing will be used to determine exercise intensity for weeks 1-6 and weeks 7-12, respectively.

Recumbent Stepping, High-Intensity Interval Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 or over
  • a self-reported diagnosis of multiple sclerosis
  • self-reported Expanded Disability Status Scale (EDSS) score \< 8.0 or Patient Determined Disability Steps (PDDS) scale score ≤ 7.0
  • relapse free in past 30 days
  • willing and able to visit Berry College or University of North Texas on three testing occasions and twenty four training occasions
  • asymptomatic status for maximal exercise testing; (g) physician approval for undertaking exercise testing
  • a self-reported ability to speak, read, and understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Texas

Denton, Texas, 76203, United States

Location

Related Publications (1)

  • Hubbard EA, Motl RW, Elmer DJ. Feasibility and initial efficacy of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability: study protocol for a single-group, feasibility trial. Trials. 2020 Nov 25;21(1):972. doi: 10.1186/s13063-020-04887-x.

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Stephanie L Silveira, PhD

    University of North Texas Health Science Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 4, 2020

Study Start

December 19, 2019

Primary Completion

December 14, 2022

Study Completion

December 14, 2022

Last Updated

April 19, 2023

Record last verified: 2023-04

Locations